Psoriasis genetics: Breaking the barrier

Trends in Genetics

Volumn 26, Issue 9, 2010, Pages 415-423

  Roberson, Elisha D O ^a   Bowcock, Anne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEHYDRATION; DISEASE ASSOCIATION; EPIDERMIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOME; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATORY DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RISK FACTOR; SKIN INFLAMMATION;

EID: 77955842799     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2010.06.006     Document Type: Review

References (89)

1. Bhalerao J., Bowcock A. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum. Mol. Genet. 1998, 7:1537-1545.
2. Boyman O., et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T Cells and tumor necrosis factor-α. J. Exp. Med. 2004, 199:731-736.
3. Arnett F.C., et al. Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum. Dis. Clin. North Am. 1991, 17:59-78.
4. Rongioletti F., et al. Psoriasis induced or aggravated by drugs. J. Rheumatol. 2009, 36(Suppl. 83):59-61.
5. Nograles K.E., et al. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat. Clin. Pract. Rheumatol. 2009, 5:83-91.
6. Gelfand J.M., et al. Risk of myocardial infarction in patients with psoriasis. J. Am. Med. Assoc. 2006, 296(14):1735-1741.
7. Gelfand J.M., et al. The risk of stroke in patients with psoriasis. J. Invest. Dermatol. 2009, 129:2411-2418.
8. Griffiths C.E.M., Barker J.N.W.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
9. Eyre R.W., Krueger G.G. Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions. Br. J. Dermatol. 1982, 106:153-159.
10. Zhou X., et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics 2003, 13:69-78.
11. Gudjonsson J.E., et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J. Invest. Dermatol. 2010, 130(7):1829-1840.
12. Mee J.B., et al. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am. J. Pathol. 2007, 171:32-42.
13. Nomura I., et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J. Allergy Clin. Immunol. 2003, 112:1195-1202.
14. Guttman-Yassky E., et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J. Allergy Clin. Immunol. 2007, 119:1210-1217.
15. Kamsteeg M., et al. Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: regulation by Th2 cytokines. J. Invest. Dermatol. 2007, 127:1786-1789.
16. +CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 2005, 174:164-173.
17. Halprin K.M. Epidermal 'turnover time' - a re-examination. Br. J. Dermatol. 1972, 86:14-19.
18. de Jongh G.J., et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol. 2005, 125:1163-1173.
19. Mansbridge J.N., et al. Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. J. Invest. Dermatol. 1984, 83:296-301.
20. Pellegrini G., et al. Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J. Clin. Invest. 1992, 89:1783-1795.
21. Guttman-Yassky E., et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J. Allergy Clin. Immunol. 2009, 124. pp. 1235.e58-1244.e58.
22. Van Ruissen F., et al. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. Journal of Cellular Physiology 1996, 168:442-452.
23. Lowes M.A., et al. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
24. Lowes M.A., et al. Current concepts in the immunopathogenesis of psoriasis. Dermatol. Clin. 2004, 22:349-369.
25. Tiilikainen A., et al. Psoriasis and HLA-Cw6. Br. J. Dermatol. 1980, 102:179-184.
26. Elder J.T., et al. The genetics of psoriasis. Arch. Dermatol. 1994, 130:216-224.
27. Bowcock A.M., Cookson W.O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 2004, 13(Review Issue 1):R43-55.
28. Tomfohrde J., et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994, 264:1141-1145.
29. Hwu W.L., et al. Mapping of psoriasis to 17q terminus. J. Med. Genet. 2005, 42:152-158.
30. Hewett D., et al. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 2002, 79:305-314.
31. Cargill M., et al. A large-scale genetic association ctudy confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 2007, 80:273-290.
32. Capon F., et al. Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Hum. Mol. Genet. 2008, 17:1938-1945.
33. Liu Y., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008, 4:e1000041.
34. Nair R.P., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 2009, 41:199-204.
35. Zhang X.-J., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 2009, 41:205-210.
36. Nair R.P., et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 2006, 78:827-851.
37. Feng B.J., et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet. 2009, 5:e1000606.
38. Zhang X.J., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 2009, 41:205-210.
39. Tsunemi Y., et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 2002, 30:161-166.
40. van Beelen A.J., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:660-669.
41. Lizzul P.F., et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J. Invest. Dermatol. 2005, 124:1275-1283.
42. Hollox E.J., et al. Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet. 2008, 40:23-25.
43. + T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J. Immunol. 2008, 181:4733-4741.
44. Huh W.K., et al. Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin. J. Mol. Med. 2002, 80:678-684.
45. Nograles K.E., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 2008, 159:1092-1102.
46. Mischke D., et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J. Invest. Dermatol. 1996, 106:989-992.
47. Bowcock A.M., et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 2001, 10:1793-1805.
48. Chen H., et al. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J. Invest. Dermatol. 2009, 129:606-614.
49. Jackson B., et al. Late cornified envelope family in differentiating epithelia - response to calcium and ultraviolet irradiation. J. Invest. Dermatol. 2005, 124:1062-1070.
50. de Cid R., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 2009, 41:211-215.
51. de Guzman Strong C., et al. A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis. Hum. Mol. Genet. 2010, 19(8):1453-1460.
52. Palmer C.N., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006, 38:441-446.
53. Zhao Y., et al. Filaggrin null alleles are not associated with psoriasis. J. Invest. Dermatol. 2007, 127:1878-1882.
54. Bergboer J.G., et al. Deletion of late cornified envelope 3B and 3C genes is not associated with atopic dermatitis. J. Invest. Dermatol 2010, 130:2057-2061.
55. Gudjonsson J.E., et al. Mouse models of psoriasis. J. Invest. Dermatol. 2007, 127:1292-1308.
56. Cook P.W., et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest. 1997, 100:2286-2294.
57. Xia Y.P., et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003, 102:161-168.
58. Kopp T., et al. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J. Immunol. 2003, 170:5438-5444.
59. Sano S., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 2005, 11:43-49.
60. + T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 2000, 13:643-655.
61. de Guzman Strong C., et al. Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J. Cell Biol. 2006, 175:661-670.
62. Segre J.A., et al. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
63. Zenz R., et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.
64. Carroll J.M., et al. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995, 83:957-968.
65. Schon M.P., et al. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat. Med. 1997, 3:183-188.
66. Taurog J.D., et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol. Rev. 1999, 169:209-223.
67. Blumberg H., et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001, 104:9-19.
68. Guo L., et al. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 1993, 12:973-986.
69. Boyman O., et al. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 2004, 199:731-736.
70. Lew W., et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'Type 1' inflammatory gene expression. Trends Immunol. 2004, 25:295-305.
71. Leclerc E.A., et al. Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction. J. Cell Sci. 2009, 122:2699-2709.
72. Begovich A.B., et al. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum. Immunol. 2007, 68:934-937.
73. Duerr R.H., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
74. Fung E.Y., et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009, 10:188-191.
75. Coenen M.J., et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet. 2009, 18:4195-4203.
76. Graham R.R., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 2008, 40:1059-1061.
77. Plenge R.M., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007, 39:1477-1482.
78. Tu C.L., et al. The role of the calcium sensing receptor in regulating intracellular calcium handling in human epidermal keratinocytes. J. Invest. Dermatol. 2007, 127:1074-1083.
79. Xie Z., et al. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol. Biol. Cell 2005, 16:3236-3246.
80. Djalilian A.R. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J. Clin. Invest. 2006, 116:1243-1253.
81. Elder J.T. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun. 2009, 10:201-209.
82. Prinz J.C., et al. Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur. J. Immunol. 1999, 29:3360-3368.
83. + T cells. Clin. Exp. Immunol. 2004, 138:83-93.
84. Huffmeier U., et al. Systematic linkage disequilibrium analysis of SLC12A8 at PSORS5 confirms a role in susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 2005, 125:906-912.
85. Segre J. Complex redundancy to build a simple epidermal permeability barrier. Curr. Opin. Cell Biol. 2003, 15:776-782.
86. Broome A.M., et al. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 2003, 51:675-685.
87. Lee K.C., Eckert R.L. S100A7 (Psoriasin) - mechanism of antibacterial action in wounds. J. Invest. Dermatol. 2007, 127:945-957.
88. Elias P.M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 2005, 125:183-200.
89. Odland G.F., Holbrook K. The lamellar granules of epidermis. Curr. Probl. Dermatol. 1981, 9:29-49.